drugs

Risankizumab can be used in patients with Crohn’s

Pharmacist naloxone program extended

Anti-inflammatories could make back pain worse

New high for medicinal cannabis prescriber numbers

Naloxone trial ‘saves three Australians a day’

Poppy seed tea leaves man with opioid addiction

TGA approves more covid drugs

Medicinal cannabis and stigma: the elephant in the room
